Clinical Trials in Illinois

Showing 15261-15280 of 19,692 trials

Persea Americana for Total Health (PATH ) Study

NCT02740439

The proposed work will investigate the effects of avocados on abdominal obesity and glycemic control among overweight/obese adults.

Obesity, AbdominalInsulin ResistanceInsulin Sensitivity

University of Illinois at Urbana-Champaign200 participantsStarted Feb 2016

Urbana, Illinois, United States

COMPLETEDPhase 4116 miles

The Jetstream (JET) Post-market Registry

NCT01436435

The scope of the JET registry to observe long term treatment effects of Jetstream Navitus on various lesions types/morphologies.

Peripheral Arterial Diseases

Boston Scientific Corporation241 participantsStarted Sep 2011

Washington D.C., District of Columbia, United States • Miami, Florida, United States • Davenport, Iowa, United States +8 more locations

COMPLETEDPhase 3121 miles

A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy

NCT01419197

This randomized, multicenter, 2-arm, open-label study (TH3RESA) will evaluate the efficacy and safety of trastuzumab emtansine (T-DM1) in comparison with treatment of the physician's choice in participants with metastatic or unresectable locally advanced/recurrent human epidermal growth factor receptor 2 (HER2)-positive breast cancer. Eligible participants will be randomized to receive either trastuzumab emtansine 3.6 mg/kg intravenously every 21 days or treatment of the physician's choice. Participants continue to receive study treatment until disease progression or unacceptable toxicity occurs. This study is also known under Roche study protocol number BO25734.

Breast Cancer

Hoffmann-La Roche602 participantsStarted Sep 2011

Tucson, Arizona, United States • Hot Springs, Arkansas, United States • Hayward, California, United States +181 more locations

Persea Americana for Total Health (PATH ) Study

The Jetstream (JET) Post-market Registry

A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy

Find Trials by Condition in Illinois

Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients

Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer

Safety and Efficacy of Vanoxerine for the Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus Rhythm

A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease

Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT

Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD

Effect of Ruboxistaurin on Clinically Significant Macular Edema

First Line Hepato Cellular Carcinoma (HCC)

Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours

A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen

Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma

Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis

A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies

Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1